These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
410 related items for PubMed ID: 20798253
1. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia. Watson M, Abbott KC, Yuan CM. Clin J Am Soc Nephrol; 2010 Oct; 5(10):1723-6. PubMed ID: 20798253 [Abstract] [Full Text] [Related]
2. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? Sterns RH, Rojas M, Bernstein P, Chennupati S. J Am Soc Nephrol; 2010 May; 21(5):733-5. PubMed ID: 20167700 [Abstract] [Full Text] [Related]
3. Acute abdomen with colonic necrosis induced by Kayexalate-sorbitol. Dardik A, Moesinger RC, Efron G, Barbul A, Harrison MG. South Med J; 2000 May; 93(5):511-3. PubMed ID: 10832954 [Abstract] [Full Text] [Related]
4. Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol. McGowan CE, Saha S, Chu G, Resnick MB, Moss SF. South Med J; 2009 May; 102(5):493-7. PubMed ID: 19373153 [Abstract] [Full Text] [Related]
5. Ileocolic perforation secondary to sodium polystyrene sulfonate in sorbitol use: a case report. Trottier V, Drolet S, Morcos MW. Can J Gastroenterol; 2009 Oct; 23(10):689-90. PubMed ID: 19826644 [Abstract] [Full Text] [Related]
6. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease. Georgianos PI, Liampas I, Kyriakou A, Vaios V, Raptis V, Savvidis N, Sioulis A, Liakopoulos V, Balaskas EV, Zebekakis PE. Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620 [Abstract] [Full Text] [Related]
7. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study. Hagan AE, Farrington CA, Wall GC, Belz MM. Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776 [Abstract] [Full Text] [Related]
8. Hyperkalemia and potential pitfalls of sodium polystyrene sulfonate. Nguyen T, Ondrik D, Zhufyak O, To W, He S. JAAPA; 2015 Mar; 28(3):41-5. PubMed ID: 25710403 [Abstract] [Full Text] [Related]
9. Cecal perforation associated with sodium polystyrene sulfonate-sorbitol enemas in a 650 gram infant with hyperkalemia. Bennett LN, Myers TF, Lambert GH. Am J Perinatol; 1996 Apr; 13(3):167-70. PubMed ID: 8688109 [Abstract] [Full Text] [Related]
10. Colonic necrosis due to oral kayexalate in a critically-ill patient. Thomas A, James BR, Landsberg D. Am J Med Sci; 2009 Apr; 337(4):305-6. PubMed ID: 19365182 [Abstract] [Full Text] [Related]
11. Kayexalate (sodium polystyrene sulphonate) in sorbitol associated with intestinal necrosis in uremic patients. Gardiner GW. Can J Gastroenterol; 1997 Oct; 11(7):573-7. PubMed ID: 9395757 [Abstract] [Full Text] [Related]
13. Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis. Lillemoe KD, Romolo JL, Hamilton SR, Pennington LR, Burdick JF, Williams GM. Surgery; 1987 Mar; 101(3):267-72. PubMed ID: 3824154 [Abstract] [Full Text] [Related]
14. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate. Lee J, Moffett BS. Pediatr Nephrol; 2016 Nov; 31(11):2113-7. PubMed ID: 27215929 [Abstract] [Full Text] [Related]
15. Asymptomatic Cecal Perforation in a Renal Transplant Recipient After Sodium Polystyrene Sulfonate Administration. Singla M, Shikha D, Lee S, Baumstein D, Chaudhari A, Carbajal R. Am J Ther; 2016 Nov; 23(4):e1102-4. PubMed ID: 25415544 [Abstract] [Full Text] [Related]
17. Colonic necrosis with Kayexalate-sorbitol enemas after renal transplantation. Wootton FT, Rhodes DF, Lee WM, Fitts CT. Ann Intern Med; 1989 Dec 01; 111(11):947-9. PubMed ID: 2817643 [No Abstract] [Full Text] [Related]
18. Sodium polystyrene sulfonate: a cation exchange resin used in treating hyperkalemia. Meyer I. ANNA J; 1993 Feb 01; 20(1):93-5. PubMed ID: 8431031 [Abstract] [Full Text] [Related]
19. Intestinal Necrosis Associated with Orally Administered Calcium Polystyrene Sulfonate Without Sorbitol. Goutorbe P, Montcriol A, Lacroix G, Bordes J, Meaudre E, Souraud JB. Ann Pharmacother; 2011 Feb 01; 45(2):e13. PubMed ID: 21304040 [Abstract] [Full Text] [Related]
20. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia. Mistry M, Shea A, Giguère P, Nguyen ML. Ann Pharmacother; 2016 Jun 01; 50(6):455-62. PubMed ID: 27048188 [Abstract] [Full Text] [Related] Page: [Next] [New Search]